NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Quantitative, not qualitative, defects characterize responses of cells from HIV+ subjects to B cell mitogens.

Edelman AS, Zolla-Pazner S; International Conference on AIDS.

Int Conf AIDS. 1989 Jun 4-9; 5: 579 (abstract no. T.C.P.74).

NYU Med. Ctr. and V.A. Hospital NY, NY, USA

OBJECTIVE: To elucidate the immunoregulatory mechanisms involved in B lymphocyte responses of cells from HIV-seropositive (HIV+) subjects. METHODS: Proliferative responses of mononuclear cells (MNC) to B cell mitogens, (anti-u and Staphylococcus aureus Cowan I [SAC]) were determined by 3H-thymidine incorporation in 3 or 4 day cultures. Mixed lymphocyte culture supernatant (MLC-sup) and indomethacin were added to certain cultures. RESULTS: Average proliferative responses of MNC from HIV+ patients to each mitogen are significantly defective (25-35% of control [HIV-] responses). Addition of MLC-sup increases responses of both HIV+ and HIV- MNC to anti-u (45% and 90% respectively) and SAC (60% in both groups). Addition of indomethacin increases responses to SAC, (60-70% increase for both groups). Effects of MLC-sup and indomethacin are additive. To determine if deficient responses were influenced by the altered frequency of lymphocyte subsets in the HIV+ cultures, correlations were sought between proliferation and percent of lymphocyte subsets. Proliferative responses to anti-u and SAC in the presence of both MLC-sup and indomethacin are correlated positively with the percent of B and CD4+ T cells, and negatively with the percent of CD8+ T cells in culture. Mathematical correction of the data for the abnormal percentages of B, CD4+ T and CD8+ T cells results in responses that are comparable to those of control cells. CONCLUSION: Deficient responses may be due to quantitative differences in the responding B cells and regulatory pathways mediated by CD4+ and CD8+ T cells and not to qualitative differences in the ability of the patients' B cells to respond to these mitogens.

Publication Types:
  • Meeting Abstracts
Keywords:
  • AIDS Vaccines
  • Acquired Immunodeficiency Syndrome
  • Antigens, CD4
  • Antigens, CD8
  • B-Lymphocytes
  • Growth Substances
  • HIV Infections
  • HIV Seropositivity
  • Humans
  • Lymphocyte Culture Test, Mixed
  • Lymphocyte Subsets
  • Mitogens
  • Pokeweed Mitogens
  • T-Lymphocytes
  • immunology
Other ID:
  • 00302989
UI: 102178933

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov